KATO KOICHI

No ORCID on file · 153 papers in corpus · active 1995-2003
1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…

1997

A thienopyrimidine derivative of formula (I) is effective as a prophylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, canc…